Abstract:Current risk stratification for stroke is still based upon percentage of carotid stenosis, despite this measure providing minimal patient-specific information on the actual risk of stroke for both symptomatic individuals without significant carotid artery stenosis as well as asymptomatic carotid stenosis patients. A continuously growing body of literature suggests that the identification and quantification of certain carotid plaque characteristics, including lipid-rich necrotic core (LRNC), thin/ruptured fibrous cap (FC), and intraplaque hemorrhage (IPH), provide a superior means of predicting future stroke. These characteristics are identifiable via magnetic resonance imaging (MRI), with most features detectable using commercially available coils and sequences utilized in routine clinical practice in as little as 4 minutes. The presence of LRNC, a thin/ruptured FC, and IPH is associated with increased risk of future stroke or TIA. Plaques with greater than 40% LRNC with a thin overlying FC are prone to rupture. LRNC is T2 hypointense and lacks enhancement on contrast enhanced T1 weighted images. Increasing LRNC size is associated with the development of new ulceration, FC rupture, increasing plaque burden, as well as fatal and nonfatal myocardial infarction, ischemic stroke, hospitalization for acute coronary syndrome (ACS), and symptom-driven revascularization, allowing for MR biomarkers of carotid plaque vulnerability to be utilized for systemic athero-thrombotic risk and not just stroke/TIA. LRNC typically shrinks with appropriate statin therapy, with PCSK9 inhibitors possibly playing a role in patients with inadequate response. Carotid plaques with IPH represent a more advanced stage of atherosclerotic disease. IPH is detectable with field strengths of both 3.0 T and 1.5 T and will demonstrate high signal on all T1 weighted imaging sequences. The presence of IPH increases the risk of future stroke in both symptomatic and asymptomatic patients, with multivariate analysis identifying IPH as a predictor of stroke, independent of percent stenosis, with no statistical difference in men vs. women, demonstrating that simple carotid stenosis measurements and traditional risk factor analysis may be inadequate in identifying patients at the highest risk for adverse cerebrovascular events. In the evaluation for recurrent stroke in recently symptomatic patients with >50% carotid stenosis, the estimated annual stroke risk is 23.2% in IPH+ patients and only 0.6% in IPH- patients, calling into question the current risk-benefit assessment for CEA. Additionally, a recent meta-analysis suggests that IPH+ plaque in patients with symptomatic <50% stenosis may be the etiology of embolic strokes previously labeled as "embolic stroke of undetermined source" (ESUS). There are no prospective drug trials testing the ability of any lipid-lowering therapies to decrease IPH and/or total plaque volume (TPV). Given the continuously increasing evidence of IPH as a significant predictor of carotid plaque progression and future adverse vascular events, trials aimed at targeted therapy for IPH represents a significant need.

Carotid Plaque Imaging and the Risk of Atherosclerotic Cardiovascular Disease

Assessment of Neovascularization Within Carotid Plaques in Patients with Ischemic Stroke

Semiautomated Characterization of Carotid Artery Plaque Features from Computed Tomography Angiography to Predict Atherosclerotic Cardiovascular Disease Risk Score.

Association of carotid atherosclerotic plaque features with acute ischemic stroke: a magnetic resonance imaging study.

Assessing the Relationship Between Atherosclerotic Cardiovascular Disease Risk Score and Carotid Artery Imaging Findings

Imaging Biomarkers of Vulnerable Carotid Plaques for Stroke Risk Prediction and Their Potential Clinical Implications.

Detecting Vulnerable Carotid Plaque and Its Component Characteristics: Progress in Related Imaging Techniques

Novel Imaging-Based Biomarkers for Identifying Carotid Plaque Vulnerability

Advances in the Imaging Studies on Association between Carotid Atherosclerotic Plaque Progression and Ischemic Cerebrovascular Events

Imaging diagnosis and research progress of carotid plaque vulnerability

Atherosclerotic Plaque Imaging by Carotid MRI

MR imaging of vulnerable carotid plaque

Association of cardiovascular risk factors and intraplaque neovascularization in symptomatic carotid plaque

Imaging of the ulcerated carotid atherosclerotic plaque: a review of the literature

Advances in noninvasive imaging for evaluating clinical risk and guiding therapy in carotid atherosclerosis

High-resolution magnetic resonance imaging of carotid atherosclerotic plaques - a correlation study with histopathology

A Feasibility Study of Carotid Elastography for Risk Assessment of Atherosclerotic Plaques Validated by Magnetic Resonance Imaging

Pearls and Pitfalls of Carotid Artery Imaging: Ultrasound, Computed Tomography Angiography, and MR Imaging

Identification of symptomatic carotid artery plaque: a predictive model combining angiography with optical coherence tomography

A Noninvasive Imaging Approach To Assess Plaque Severity: The Carotid Atherosclerosis Score

Diagnostic accuracy of carotid plaque instability by noninvasive imaging: a systematic review and meta-analysis